Year :
2020
| Month :
June
| Volume :
14
| Issue :
6
| Page :
LE01 - LE04
Full Version
The Emergence of Novel SARS-CoV-2 (COVID-19) a Triple Reassortant Corona Virus Immunogenicity and Reactogenicity in Human
Published: June 1, 2020 | DOI: https://doi.org/10.7860/JCDR/2020/44381.13761
Debasish Pradhan, Gitanjali Tripathy, Shaktiprasad Pradhan, Bandana Behera, Adyasa Samantaray
1. Associate Professor, University Department of Pharmaceutical Sciences, Utkal University, Bhubaneswar, Odisha, India.
2. Lecturer, Department of Pharmacy, Government Polytechnic, Bhubaneswar, Odisha, India.
3. Assistant Professor, University Department of Pharmaceutical Sciences, Utkal University, Bhubaneswar, Odisha, India.
4. Assistant Professor, University Department of Pharmaceutical Sciences, Utkal University, Bhubaneswar, Odisha, India.
5. PhD Scholar, University Department of Pharmaceutical Sciences, Utkal University, Bhubaneswar, Odisha, India.
Correspondence Address :
Dr. Debasish Pradhan,
Department of Pharmaceutical Sciences, Utkal University, Bhubaneswar, Odisha, India.
E-mail: deba_udps@yahoo.co.in
Abstract
Presently, the emergence of a novel human corona virus, Severe Acute Respiratory Syndrome (SARS)-CoV-2, has lead to a global health concern. It causes severe respiratory tract infections in humans. WHO on March 11, 2020, declared COVID-19 (Corona Virus) as a pandemic. There have been more than 3,842,000 confirmed COVID-19 cases in the world. The reports have shown sharp increase in the number of infections reported in recent days from Italy, Iran, South Korea, Spain, Germany, United States, and other parts of the world, with the most dramatic increase recorded in China where more than 80,000 cases were reported in a very short duration. Neither potential medication nor vaccines are available in the market and the virus can manifest itself both symptomatically and asymptomatically in the human system.
Keywords
Corona virus (COVID-19), Hydroxychloroquine, Pandemic, Remdesivir, Solidarity, Symptomatic
DOI: 10.7860/JCDR/2020/44381.13761
Date of Submission: Mar 18, 2020
Date of Peer Review: Apr 13, 2020
Date of Acceptance: Apr 28, 2020
Date of Publishing: Jun 01, 2020
AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was informed consent obtained from the subjects involved in the study? NA
• For any images presented appropriate consent has been obtained from the subjects. NA
PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Mar 19, 2020
• Manual Googling: Apr 20, 2020
• iThenticate Software: May 11, 2020 (32%)
ETYMOLOGY: Author Origin
|